Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;339(2):324-8.
doi: 10.1124/jpet.111.183285. Epub 2011 Aug 17.

Drug discontinuation effects are part of the pharmacology of a drug

Affiliations

Drug discontinuation effects are part of the pharmacology of a drug

Marcus M Reidenberg. J Pharmacol Exp Ther. 2011 Nov.

Abstract

Most reviews of drug withdrawal effects focus on drugs of potential abuse such as opioids, benzodiazepines, etc. Abrupt discontinuation of many other drugs used in medicine cause withdrawal syndromes, some of which can be fatal. Discontinuation of a number of cardiovascular drugs can increase risk of cardiovascular events above that of people not taking these drugs. These include β-adrenergic receptor antagonists, aspirin, HMG-CoA reductase inhibitors (statins), and heparin. Rebound hypertension occurs after abrupt cessation of many antihypertensive drugs. The possibility of discontinuation syndromes has usually been neglected until adverse clinical events force them to be noticed. Attention to the possibility of drug discontinuation effects is an important part of drug safety evaluation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alderman EL, Coltart DJ, Wettach GE, Harrison DC. (1974) Coronary artery syndromes after sudden propranolol withdrawal. Ann Int Med 81:625–627 - PubMed
    1. Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ. (2002) Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin. J Am Coll Cardiol 39:811–817 - PubMed
    1. Bijsterveld NR, Peters RJ, Murphy SA, Bernink PJ, Tijssen JG, Cohen M. (2003) Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies. J Am Coll Cardiol 42:2083–2089 - PubMed
    1. Black K, Shea C, Dursun S, Kutcher S. (2000) Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 25:255–261 - PMC - PubMed
    1. Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, et al. (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69:904–910 - PubMed

Publication types

MeSH terms

Substances